Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(13):984; doi:10.1093/jnci/96.13.984
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Rice, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rice, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Directive Threatens Clinical Research in Europe, Critics Say

Mary Rice

The first 10% of the full text of this article appears below.

The new European Union directive on clinical trials was scheduled to be implemented in all member states by May 1. However, many countries have not fully integrated the directive into clinical practice, and several noncommercial research organizations and patient groups throughout Europe are increasingly voicing their concern for the future of academic clinical trials.

The directive, which was adopted in 2001, is supposed to simplify and harmonize clinical trials work by creating a single legal framework for drug trials in member states (. . . [Full Text of this Article]

Possibility for Amendment

Increasing Trial Costs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?